Abstract

Purpose. To characterise phenotypic heterogeneity of renal macrophage infiltration and its relationships with clinical and medical history data in patients who died at different times after myocardial infarction (MI).Material and Methods. We analyzed the material (kidney sections) collected from patients (n = 30) who died from type 1 MI. Renal macrophage infiltration was assessed by the immunohistochemistry method using antibodies to CD68, CD80, CD163, CD206, and stabilin-1.Results. The study included patients with MI aged 74.8 ± 9.8 years. ST-segment elevation myocardial infarction (STEMI) was diagnosed in 87% of patients; the creatinine level was 115.1 ± 79 μmol/L at admission to hospital. The study showed a significant heterogeneity of macrophage phenotypes in renal tissue: the counts of CD163+, CD68+, CD206+, CD80+, and stabilin-1+ cells were 55 (27; 55), 30 (27; 56), 4 (2; 6), 3 (2; 5), and 2 (1; 3) per field of view, respectively. The CD163+ and CD68+ macrophages were predominant cell types in patients who died within three days after MI onset (p < 0.05). In case of fatal outcome that occurred after three days of MI, the count of CD163+ cells was the highest and exceeded the number of СD68+ cells, which, nevertheless, prevailed over other cell phenotypes (p < 0.05). Starting from day 4 of MI, the counts of CD206+ cells decreased from 6 (5; 8) to 2 (1; 2) similarly to a decrease in CD80+ count from 5 (3; 5) to 2 (1; 2) (p < 0.05). The rate of adverse cardiovascular complications and the severity of coronary lesions were associated with CD80+ and CD206+ cell counts; the development of left ventricular aneurysm was associated with the numbers of stabilin-1+ and CD163+ cells.Conclusion. Renal macrophage infiltration was characterized by a pronounced cellular heterogeneity that depended on the timing of death after MI. The CD163+ and CD68+ cells predominated at the early stages of MI; the CD163+ cells were predominant at the later stages. The CD80+ and CD206+ cell counts changed quantitatively, decreasing from day 4 of MI. The presence of multiple correlation relationships between the cells of macrophage lineage in the kidneys and the development of adverse cardiovascular complications in patients with MI provides rationale for further studies.

Highlights

  • Наличие кардиоренального синдрома (КРС) осложняет течение постинфарктного периода в 40% случаев [1, 2] и служит барьером для улучшения прогноза и снижения смертности у пациентов с инфарктом миокарда (ИМ) [3]

  • При этом количество CD163+ и CD68+ клеток в раннюю фазу ИМ было значимо выше, чем клеток с иными фенотипами (p = 0,0001), наименьшим было количество стабилин-1+ клеток (p = 0,001)

  • Clinical and medical history characteristics of patients enrolled in the study

Read more

Summary

Особенности макрофагальной инфильтрации почек у пациентов с инфарктом миокарда

Аннотация Цель: определить особенности фенотипического состава макрофагальной инфильтрации почек и его взаимосвязи с клинико-анамнестическими данными у пациентов, умерших в разные сроки после инфаркта миокарда (ИМ). Анализировался материал (срезы почек), забранный у пациентов (n = 30), умерших от ИМ I типа. Выявлена выраженная гетерогенность фенотипов клеток в ткани почек: количество CD163+ клеток составило 55 (32; 97), CD68+ 30 (23; 51), CD206+ 4 (2; 6), CD80+ 3 (2; 5), стабилин-1+ 2 (1; 3). У пациентов с наступлением летального исхода до 3-х сут ИМ преобладали клетки CD163+ и CD68+ (p < 0,05). В случае наступления летального исхода после 3-х сут ИМ количество CD163+ клеток было максимальным, клеток СD68+ было меньше, однако их количество преобладало над количеством клеток с иными фенотипами (p < 0,05). Керчева М.А., Рябов В.В., Ребенкова М.С., Ким Б., Рябцева А.Н., Колмаков А.А., Гомбожапова А.Э., Кжышковска Ю.Г. Особенности макрофагальной инфильтрации почек у пациентов с инфарктом миокарда.

Материал и методы
Причина смерти Cause of death
Параметры клетки Сells
Информация о вкладе авторов
Information on author contributions
Findings
Information about the authors
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.